Recombinant photoproteins and their conjugates
AssigneeChisso Corporation
InventorSatoshi Inouye
Life of this patent
Estimating the term…
Loading patent…
AssigneeChisso Corporation
InventorSatoshi Inouye
Estimating the term…
This invention is to provide a photoprotein which binds with a ligand specific for a substance to be detected at a binding ratio of 1:1 such that the luminescence activity is not reduced by binding with the ligand, a conjugate comprising the luminescent photoprotein and ligand, and a substance detection method which employs the conjugate as a marker. A calcium-binding photoprotein is produced having cysteine residue introduced within the 4th amino acid residue from the amino-terminus. A conjugate is formed by binding a ligand specific for a substance to be detected to the calcium-binding photoprotein, in a binding ratio of 1:1, via the introduced cysteine residue. The conjugate may be utilized as a marker for a substance to be detected.
A recombinant calcium-binding photoprotein comprising a wild-type or mutant apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the wild-type apoprotein.
DNA coding for an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein.
A conjugate wherein a ligand specific for a substance to be detected binds to a recombinant calcium-binding photoprotein comprising a wild-type or mutant apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the wild-type apoprotein, via said cysteine residue, in a ratio of 1:1.
A method for producing a conjugate, which comprises producing by genetic engineering an apoprotein having one cysteine residue introduced within the 4th amino acid residue from the amino terminus of the amino acid sequence of wild-type apoprotein listed as SEQ. ID. No.1 or its mutant apoprotein, treating the apoprotein with coelenterazine in the presence of molecular oxygen to yield a recombinant calcium-binding photoprotein, and binding the photoprotein via the introduced cysteine residue to a ligand specific for a substance to be detected, in a ratio of 1:1.
Dependencies are inferred from the claim text.